Coast To Coast Tribune
SEE OTHER BRANDS

The latest news from the United States

Coast To Coast Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Coast To Coast Tribune.

Press releases published on May 30, 2025

Range Declares Quarterly Dividend

Range Declares Quarterly Dividend

FORT WORTH, Texas, May 30, 2025 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE: RRC) today announced that its Board of Directors declared a quarterly cash dividend on its common stock for the second quarter. A dividend of $0.09 per common share is …

Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025

PRINCETON, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in June. Jefferies Global Healthcare Conference 2025 in …

PLBY Group Selected for Inclusion in Russell Microcap® Index

PLBY Group Selected for Inclusion in Russell Microcap® Index

LOS ANGELES, May 30, 2025 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (Nasdaq: PLBY) (the “Company” or “PLBY Group”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most recognizable and iconic brands in the world, today …

G-III Apparel Group Announces Date for First Quarter Fiscal 2026 Results

G-III Apparel Group Announces Date for First Quarter Fiscal 2026 Results

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NASDAQ: GIII) a global fashion leader with expertise in design, sourcing, and marketing, today announced that it will release its first quarter fiscal 2026 earnings before the market …

Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference

Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference

DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil"), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced that Bronson Crouch, Chief Executive Officer, will present at …

OTC Markets Group Welcomes Badger Infrastructure Solutions Ltd. to OTCQX

OTC Markets Group Welcomes Badger Infrastructure Solutions Ltd. to OTCQX

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Badger Infrastructure Solutions Ltd. (TSX: BDGI; OTCQX: BDGIF), North …

Ascend Aesthetic Partners Welcomes David Cutter as COO

Ascend Aesthetic Partners Welcomes David Cutter as COO

ATLANTA, May 30, 2025 (GLOBE NEWSWIRE) -- Ascend Aesthetic Partners (Ascend) is pleased to announce the addition of David Cutter as Chief Operating Officer. Cutter is a passionate leader who reflects our values of excellence, compassion, community, and …

Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series

Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series

SOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced the launch of its inaugural Proteomics Roundtable Series – a program of virtual events designed to spark conversation about the rapidly …

Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis

Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis

FREDERICK, Md., May 30, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (“Cartesian” or the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that the first participant …

Arvinas to Present at Jefferies Global Healthcare Conference

Arvinas to Present at Jefferies Global Healthcare Conference

NEW HAVEN, Conn., May 30, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that management will participate in a …

Hyperscale Data Announces 35 Consecutive Monthly Cash Dividend Payments Timely Paid for Series D Cumulative Redeemable Perpetual Preferred Stock

Hyperscale Data Announces 35 Consecutive Monthly Cash Dividend Payments Timely Paid for Series D Cumulative Redeemable Perpetual Preferred Stock

LAS VEGAS, May 30, 2025 (GLOBE NEWSWIRE) -- Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company”), today announced that it has successfully paid 35 consecutive monthly cash dividends for its 13.00% …

Eos Energy Enterprises, Inc. Announces Pricing of Common Stock Offering

Eos Energy Enterprises, Inc. Announces Pricing of Common Stock Offering

EDISON, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”) today announced the pricing of an offering of 18,750,000 shares of common stock at a price to the public of $4.00 per share (the “Offering …

Eos Energy Enterprises, Inc. Prices Upsized $225,000,000 Convertible Senior Notes Offering

Eos Energy Enterprises, Inc. Prices Upsized $225,000,000 Convertible Senior Notes Offering

EDISON, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”) today announced the pricing of its offering of $225,000,000 aggregate principal amount of 6.75% convertible senior notes due 2030 (the “ …

URGN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead the UroGen Class Action Lawsuit

URGN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead the UroGen Class Action Lawsuit

SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman …

Aimfinity Investment Corp. I Announces Transition from Nasdaq to OTC Markets and New Monthly Extension for Business Combination

Aimfinity Investment Corp. I Announces Transition from Nasdaq to OTC Markets and New Monthly Extension for Business Combination

Wilmington, DE, May 30, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the “AIMA”) (Nasdaq: AIMTF), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which …

Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer

Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer

Zanidatamab is the first and only dual HER2-targeted bispecific antibody approved for HER2+ biliary tract cancer in China; conditional approval based on the results of the HERIZON-BTC-01 clinical study $20 million milestone payment to be received from …

Best VPN for Streaming (2025): IPVanish Recognized as Top Streaming VPN by Software Experts

Best VPN for Streaming (2025): IPVanish Recognized as Top Streaming VPN by Software Experts

NEW YORK CITY, May 30, 2025 (GLOBE NEWSWIRE) -- Software Experts has recognized IPVanish as the Best VPN for Streaming in 2025, citing its strong performance across speed, server coverage, privacy features, and usability. The review highlights IPVanish’s …

World Vape Day 2025 Marks 20 Years of Tobacco Harm Reduction Progress

World Vape Day 2025 Marks 20 Years of Tobacco Harm Reduction Progress

BRUSSELS, May 30, 2025 (GLOBE NEWSWIRE) -- Today, the global vaping community celebrates World Vape Day 2025, highlighting two decades of innovation and scientific advancement in tobacco harm reduction. This year’s theme, “20 Years of Facts”, underscores …

Bitget Lists Sophon (SOPH) in the Innovation and Public Chain Zone

Bitget Lists Sophon (SOPH) in the Innovation and Public Chain Zone

Victoria, Seychelles, May 30th, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of Sophon (SOPH) in its Innovation and Public Chain Zone. Deposits for SOPH are currently open. Spot trading will begin …

Enterome presents positive Phase 1/2 MSS/pMMR metastatic colorectal cancer data in patients treated with EO4010 OncoMimics™ immunotherapy plus nivolumab at ASCO 2025

Enterome presents positive Phase 1/2 MSS/pMMR metastatic colorectal cancer data in patients treated with EO4010 OncoMimics™ immunotherapy plus nivolumab at ASCO 2025

Survival in 20 patients with MSS/pMMR mCRC at a median follow-up of 15.4 months was 40% at 12 months; median survival is currently 11.3 months Survival has currently reached plateau, with 34% (7/20) of patients still alive 80% of patients treated with …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service